President Trump Announces New Deals with Pharmaceutical Manufacturers to Lower Drug Prices

President Donald J. Trump announced new agreements with nine additional pharmaceutical manufacturers to lower prescription drug prices for Americans. These deals, part of the "most-favored-nation" (MFN) pricing initiative, aim to align U.S. drug prices with the lowest prices paid by other developed nations. The agreements cover drugs for various conditions and are expected to result in billions of dollars in savings for State Medicaid programs.